DOI QR코드

DOI QR Code

The Effects of Jodeungsan Pharmacopuncture at GB20 on Cognitive Impairment Induced by Focal Brain Injury in Rats

풍지(風池)(GB20) 조등산(釣藤散) 약침이 국소 뇌손상으로 유발된 흰쥐의 인지장애에 미치는 영향

  • Hyun, Min Kyoung (Department of Acupuncture & Moxibustion Medicine, Dongseo Korean Medical Hospital) ;
  • Mo, Min Ju (Department of Acupuncture & Moxibustion Medicine, Dongseo Korean Medical Hospital) ;
  • Hwang, Doo Ree (Department of Acupuncture & Moxibustion Medicine, Dongseo Korean Medical Hospital) ;
  • Yang, Tae Jun (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Dongshin University) ;
  • Lee, Jung Hun (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Dongshin University) ;
  • Lee, Eun Ji (Department of Acupuncture & Moxibustion Medicine, Chung-Yeon Korean Medical Hospital) ;
  • Yoon, Tae Kyung (Department of Acupuncture & Moxibustion Medicine, Bu-Cheon Jaseng Hospital of Korean Medicine) ;
  • Youn, Dae Hwan (Department of Merdian & Acupoint, College of Korean Medicine, Dongshin University)
  • 현민경 (동서한방병원 침구의학과) ;
  • 모민주 (동서한방병원 침구의학과) ;
  • 황두리 (동서한방병원 침구의학과) ;
  • 양태준 (동신대학교 한의과대학 침구의학교실) ;
  • 이정훈 (동신대학교 한의과대학 침구의학교실) ;
  • 이은지 (청연한방병원 침구의학과) ;
  • 윤태경 (부천자생한방병원 침구의학과) ;
  • 윤대환 (동신대학교 한의과대학 경혈학교실)
  • Received : 2016.11.09
  • Accepted : 2016.12.02
  • Published : 2016.12.20

Abstract

Objectives : This research was performed to investigate the effects of Jodeungsan pharmacopuncture(PA-J) of focal brain ischemia induced by middle cerebral artery occlusion(MCAO) in rats. Methods : The subjects were divided into 4 groups : control, acupuncture, pharmacopuncture PA-J1(11.43 mg / 250 g / $40{\mu}{\ell}$) and pharmacopuncture PA-J2(2.29 mg / 250 g / $40{\mu}{\ell}$). The focal brain ischemia was induced by intraluminal filament insertion into the middle cerebral artery. After 3 days of MCAO, Jodeungsan pharmacopuncture treatment was performed on the GB20, and the day after being treated with pharmacopuncture, the Morris water maze test was carried out on the assigned group. The series of processes were administered 6 times. Thereafter mGluR5, density of neuronal cell and ChAT were measured. Results : The results were as follows. 1. The distance to target significantly decreased in the 2nd trial of the Acu group on the water maze test for short-term memory. 2. The distance to target significantly decreased in the 4th trial of the PA-J2 group on the water maze test for long-term memory. 3. The intensity of mGluR5 significantly increased in the PA-J1 group compared with the control group. 4. The neuroprotective effect on the hippocampal CA1 significantly increased in the PA-J1 and PA-J2 groups compared with the control group. 5. The density of ChAT in the hippocampal CA1 significantly increased in the PA-J1 and PA-J2 groups compared with the control group. Conclusion : These results suggest that Jodeungsan pharmacopuncture may improve memory and cognitive impairment and also have neuroprotective effects on focal brain ischemia.

Keywords

References

  1. Min SK. Modern psychiatry. 6th ed. Seoul : Il-chokak. 2015 : 229-31.
  2. Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol. 2009 ; 5(12) : 649-58. https://doi.org/10.1038/nrneurol.2009.175
  3. Park SA, Yun YH, Park JY et al. The Distribution of Dementia Subtypes and Their Neuropsychological Characteristics. Journal of Soonchunhyang Medical Science. 2009 ; 14(3) : 541-6.
  4. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010 ; 120(3) : 287-96. https://doi.org/10.1007/s00401-010-0718-6
  5. Choi SH, Ku SK, Choen WH et al. Diagnosis, Treatment and Prevention of Subcortical Vascular Dementia with a Case Report. Kor. J oriental preventive medical society. 2010 ; 14(3) : 63-75.
  6. Roman GC. Vascular dementia revisited : diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002 ; 86(3) : 477-99. https://doi.org/10.1016/S0025-7125(02)00008-1
  7. The Korean Neurosurgical Society. Neurosurgery. 3rd ed. Seoul : Joongang. 2005 : 242-3, 582.
  8. Jeongughanuigwadaehag Hanuihagjeonmun-daehagwon Gyeonglaggyeonghyeolhag Gyojaepyeonchanwiwonhoe. Details of Meridians & Acupoints(Volume II). Gangwon: Uibang. 2008 : 981.
  9. Heo SM. Bojebonsabang. Shanghai : Gwahaggisulchulpansa. 1978 : 31.
  10. Jin JS, Kwon DY. A review on pharmacological properties of Jodeungsan. Herbal formula science. 2008 ; 16(1) : 55-64.
  11. Mizushima Y, Kan S, Yoshida S, Irie Y, Urata Y. Effect of Choto-san, a Kampo medicine, on impairment of passive avoidance performance in senescence accelerated mouse (SAM). Phytother Res. 2003 ; 17(5) : 542-5. https://doi.org/10.1002/ptr.1193
  12. Yokoyama K, Shimada Y, Hori E et al. Protective effects of Choto-san and hooks and stems of Uncaria sinensis against delayed neuronal death after transient forebrain ischemia in gerbil. Phytomedicine. 2004 ; 11(6) : 478-89. https://doi.org/10.1016/j.phymed.2003.04.001
  13. Obi R, Tohda M, Zhao Q et al. Chotosan enhances macrohpage colony-stimulation factor mRNA expression in the ischemic rat brain and C6Bu-1 glioma cells. Biol Pharm Bull. 2007 ; 30(12) : 2250-6. https://doi.org/10.1248/bpb.30.2250
  14. Murakami Y, Zhao Q, Harada K, Tohda M, Watanabe H, Matsumoto K. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol Biochem Behav. 2005 ; 81(3) : 616-25. https://doi.org/10.1016/j.pbb.2005.05.004
  15. Watanebe H, Zhao Q, Matsumoto K et al. Pharmacological evidence for antidementia effect of Choto-san(Gouteng-san), a traditional Kampo medicine. Pharmacol Biochem Behav. 2003 ; 75(3) : 635-43. https://doi.org/10.1016/S0091-3057(03)00109-6
  16. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989 ; 20(1) : 84-91. https://doi.org/10.1161/01.STR.20.1.84
  17. Kenneth W, Linsay. Neurology and Neurosurgery Illustrated. 4th ed. Seoul : E public. 2006 : 414-24, 607-8.
  18. Kurz A, Perneczky R. Neurobiology of cognitive disorders. Curr Opin Psychiatry. 2009 ; 22(6) : 546-51. https://doi.org/10.1097/YCO.0b013e328330588b
  19. Glenner GG, Wong CW. Alzheimer's disease : initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 ; 120(3) : 885-90. https://doi.org/10.1016/S0006-291X(84)80190-4
  20. Iadecola C. The pathobiology of vascular dementia. Neuron. 2016 ; 80(4) : 844-66. https://doi.org/10.1016/j.neuron.2013.10.008
  21. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 ; 66(2) : 200-8. https://doi.org/10.1002/ana.21706
  22. Hachinski V, Iadecola C, Petersen RC et al. National institute of neurological disorders and stroke-canadian stroke network vascular coginitive impairment harmonization standards. Stroke. 2006 ; 37(9) : 2220-41. https://doi.org/10.1161/01.STR.0000237236.88823.47
  23. Gill R, Foster AC, Woodruff GN. MK-801 is neuroprotective in gerbils when administered during the post-ischemic period. Neuroscience. 1988 ; 25(3) : 847-55. https://doi.org/10.1016/0306-4522(88)90040-1
  24. Kirino T, Tamura A, Sano K. Selective vulnerability of the hippocampus to ischemia-reversibel and irreversibel types of ischemic cell damage. Prog Brain Res. 1985 ; 63 : 39-58.
  25. Fujisawa A, Matsumoto M, Matsuyama T et al. The effect of the calciumantagonist nimodipine on the gerbil model of experimental cerebral ischemia. Stroke. 1986 ; 17(4) : 748-52. https://doi.org/10.1161/01.STR.17.4.748
  26. Lee YJ, Han CH, Jeon WK, Baek KM, Cheon WH, Choi SH. A review study of treatment effects for vascular dementia. Kor. J. Oriental Preventive Medical Society. 2011 ; 15(2) : 51-67.
  27. Lee DW, Shin GJ, Lee WC. A Comparative Consideration of Treatment on Dementia in Oriental and Occidental Medicine. The Journal of Dong Guk Oriental Medicine. 1995 ; 4(3) : 67-80.
  28. Kim HK, Shin SW, Kwon JY, Baik SW, Kim IS, Chung KS. A Study on Animal Experimentation for Brain Ischemia. Korean Journal of Critical Care Medicine. 1997 ; 12(2) : 206.
  29. Adams RD, Victor M, Ropper AH. Principles of Neurology. 6th ed. Seoul : Jeongdam. 1998 : 715-21.
  30. Han SG, Lee BR. Effects of Angelica gigas Nakai herbal acupuncture into Hyolhae(SP10) of brain ischemic injury induced by Intraluminal Filament insertion in the rats. The Acupunct. 2004 ; 21(2) : 1-20.
  31. Suk JW, Jung TY, Lim SC et al. The Protective Effect of Hirudin Herbal-acupuncture against the Neuronal Damage Induced by Middle Cerebral Artery Occlusion(MCAO) in Rats. The Acupunct. 2004 ; 21(4) : 207-15.
  32. Youn DH, Lee BB, Shim IS, Na CS. Effects of BCL herbal acupuncture into Choksamni(ST36) on focal brain ischemic injury induced by intraluminal filament insertion in the rats. The Korean Journal of Meridian & Acupoint. 2005 ; 22(2) : 25-41.
  33. Kim KS, Youn DH, Hong S, Na CS. Effects of Cnidium officinale(CO) extracts through administrated by means of oral and herbal acupuncture method at GB21 acupoint on focal ischemic brain injury induced by MCAO in rats. The Korean Journal of Meridian & Acupoint. 2005 ; 22(3) : 137-56.
  34. Kim SO, Youn DH, Na CS. Effect of Cervus Elaphus-Herbal acupuncture on Focal Ischemia Induced by Inserted Intraluminal Filament in MCA of Rats. The Korean Journal of Meridian & Acupoint. 2005 ; 22(4) : 67-81.
  35. Lee SJ, Jeong HW. Effects of Phamacopuncture Therapy Using Cervi Pantotrichum Cornu at BL23 . BL52 on the Cerebral Hemodynamics in Rats. Korean J. Oriental Physiology & Pathology. 2009 ; 23(1) : 50-6.
  36. Jang YJ. The Effect of Acori Graminie Rhizoma Pharmacopuncture at GV20 on Dementia in Focal Cerebral Ischemia Rat Model [dissertation]. Naju : Dongshin Univ. 2016. Korean.
  37. Na GH, Youn DH, Na CS, Chae WS. Anti-apoptotic and Neuroprotective Effects of Gastrodiae Elata Pharmacupuncture at GB20 on Focal Brain Ischemic Injury Induced by Intraluminal Filament Insertion in Rats. The Acupunct. 2008 ; 25(1) : 1-14.
  38. Lee JH, Yang TJ, Jeong SJ, Wei TS. Effects of Ukgansan Pharmacopuncture at GB20 on Cognitive Impairment Induced by Focal Brain Injury in Rats. The Acupunct. 2016 ; 33(3) : 101-16. https://doi.org/10.13045/acupunct.2016038
  39. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982 ; 11(5) : 491-8. https://doi.org/10.1002/ana.410110509
  40. Yamazaki M, Matsuoka N, Maeda N, Kuratani K, Ohkubo Y, Yamaguchi I. FR121196, a potential antidementia drug, ameilorates the impaired memory of rat in the Morris water maze. J Pharmacol Exp Ther. 1995 ; 272(1) : 256-63.
  41. Chung BK, Yoon BS, Park SK. EFFECTS of MEDIAL SEPTAL LESIONS on MORRIS WATER MAZE LEARNING in RATS. The Korean Journal of Cognitive and Biological Psychology. 1993 ; 5 : 29-44.
  42. Jung HK, Shin KY, Suh YH. Differences in rat's behavioral propensity about learning and memory or drug effect. Proceedings of the Korean Society for Cognitive Science Conference. 2005 May 28 ; Seoul, Korea. Seoul : Antscommunication. 2005.
  43. Diamond DM, Fleshner M, Ingersoll N, Rose GM. Psychological stress impairs spatial working memory : relevance to electrophysiological studies of hippocampal function. Behav Neurosci. 1996 ; 110(4) : 661-72. https://doi.org/10.1037/0735-7044.110.4.661
  44. Maiese K, Swiriduk M, TenBroeke M. Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity. J Neurochem. 1996 ; 66(6) : 2419-28.
  45. Baskys A, Bayazitov I, Fang L, Blaabjerg M, Poulsen FR, Zimmer J. Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis. Neuropharmacology. 2005 ; 49 Suppl 1 : 146-56. https://doi.org/10.1016/j.neuropharm.2005.04.029
  46. Yeh TH, Wang HL. Global ischemia downregulates the function of metabotropic glutamate receptor subtype 5 in hippocampal CA1 pyramidal neurons. Mol Cell Neurosci. 2005 ; 29(3) : 484-92. https://doi.org/10.1016/j.mcn.2005.04.001
  47. Amet LE, Lauri SE, Hienola A et al. Enhanced hippocampal long-term potentiation in mice lacking heparin-binding growth-associated molecule. Mol Cell Neurosci. 2001 ; 17(6) : 1014-24. https://doi.org/10.1006/mcne.2001.0998
  48. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus : MRI volumetry confirms widespread limbic atrophy in AD. Neurology. 2001 ; 57(9) : 1669-74. https://doi.org/10.1212/WNL.57.9.1669
  49. Park SI, Oh KH, Hwang JW et al. Effect of Bupleuri Radix on c-Fos and c-Jun Expression in Ischemic Damaged Hippocampus of the Aged BCAO Rats. Korean J. Oriental. Int. Med. 2005 ; 26(3) : 533-42.
  50. Quirion R. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J Psychiatry Neurosci. 1993 ; 18(5) : 226-34.
  51. Soininen H, Halonen T, Riekkinen PJ. Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand. 1981 ; 64(3) : 217-24. https://doi.org/10.1111/j.1600-0447.1981.tb00777.x
  52. Ishimaru H, Takahashi A, Ikarashi Y, Maruyama Y. Effects of MK-801 and pentobarbital on cholinergic terminal damage and delayed neuronal death in the ischemic gerbil hippocampus. Brain Res Bull. 1997 ; 43(1) : 81-5. https://doi.org/10.1016/S0361-9230(96)00347-4

Cited by

  1. Systematic Review of Acupuncture Treatment for Mild Cognitive Impairment vol.36, pp.2, 2016, https://doi.org/10.13045/jar.2019.00108
  2. 외상성 경막외 출혈 이후 발생한 인지장애에 대한 한방치료 1례 vol.40, pp.5, 2019, https://doi.org/10.22246/jikm.2019.40.5.920